Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax:
+1 801-751-5728
info@pharmachinaonline.com
Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel:
+86 10 84476010
info@pharmachinaonline.com
Industry News
4/20/2021
Snapshot of Nine China-originated New Drugs under BLA/NDA and Approved...
4/20/2021
AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater ...
(Free)
4/20/2021
China Experiments Mixing Two Homegrown Covid Vaccines to Bolster Eff...
4/20/2021
iX Biopharma and SinoPharm Enter Distribution Deal for the Chinese ...
4/20/2021
GlobalData: Cheap Chinese ICIs May Shake Global Oncology Market
4/20/2021
Citrine Med and Sinopharm Enter Partnership to Enhance Access to Rare ...
4/19/2021
A Share-Listed Chinese MedPharm Cos Report Performance in 2020 and Q1/...
4/16/2021
Sinopharm to Inject $4.6 bln Vaccine Assets into Unit Tiantan Biologic...
(Free)
4/16/2021
Biogen's Tecfidera Approved in China for Relapsing Multiple Sclerosis
4/15/2021
Hugel Expands China Presence with New Subsidiary in Shanghai
4/15/2021
Lonza to Make Junshi Biosciences Antibody at China Facility
4/15/2021
Kintor and Visum Announced Strategic Partnership to Expand Proxalutami...
4/14/2021
Eli Lilly Licenses Greater China Rights of Alpha-synuclein Targeted Th...
4/14/2021
BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...
4/14/2021
Denovo's Licenses DB102 (Enzastaurin) for Rare Genetic Pediatric Onset...
(Free)
4/14/2021
StoneWise Raises $100M to Promote Use of AI in Drug Development
(Free)
4/14/2021
AZ's Tagrisso Approved in China as Adjuvant Treatment for Early EGFRm ...
4/14/2021
Sanofi Unveils New R&D Facility in Suzhou
4/13/2021
Pharma MNCs Step Up Alliances with Local Players in Chinese Market
4/13/2021
Abcam and MEDx Extend Precision Medicine Strategic Partnership
4/12/2021
Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock
4/12/2021
Review of R&D Spending of Listed Chinese Biopharma Firms 2018-2020
4/8/2021
BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Waldenström'...
(Free)
4/8/2021
BeiGene's Guangzhou Biologics Plant Granted First Commercial Manufactu...
4/8/2021
Biogen and Bio-Thera Solutions Announce License Deal for Actemra Biosi...
4/8/2021
Clinigen Launches Managed Access Program with BeiGene for Zanubrutinib
4/7/2021
Chime Bio Builds Second Biomanufacturing Facility in Wuhan After Rais...
4/6/2021
iX Biopharma Enters Cooperation Deal with China Resources Pharma Comme...
4/6/2021
Snapshot of New Chinese biopharma IPOs 2019-2020
4/6/2021
Crystec Launches New R&D Center in China
(Free)
Page:
1
/
19
Total number of articles:
570
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit